In general, ghrelin inhibits metabolic disorders and the apoptosis of NP cells by inhibiting the IL‐1β‐induced NK‐κB signalling pathway and stimulates the anabolic metabolism of NP cells by activating the AKT signalling pathway, thus providing a protective effect on IVD. This evidence concerns the gene AKT1 and Other metabolic disease.